TRIM24 and neoplasm: More interestingly, patients with TRIM24 overexpression showed poor differentiation (P = 0.004), higher level of AFP (P = 0.036), higher incidence of intrahepatic metastasis (P = 0.004) and recurrence (P = 0.000006), and shorter Tumor-free survival time (P = 0.002) (Figure 2).